Pantoprazole Sodium
NDC 43353-338
Product Information
Pantoprazole Sodium is a NDA-approved product labeled by Aphena Pharma Solutions - Tennessee, Llc. Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It is supplied as a yellow product. This product entry covers the primary NDC 43353-338 and 6 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
P;40
Code Structure Chart
Product Details
What is NDC 43353-338?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- PANTOPRAZOLE SODIUM (UNII: 6871619Q5X)
- PANTOPRAZOLE (UNII: D8TST4O562) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CALCIUM STEARATE (UNII: 776XM7047L)
- CROSPOVIDONE (UNII: 68401960MK)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- MANNITOL (UNII: 3OWL53L36A)
- METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A (UNII: NX76LV5T8J)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- POVIDONE K25 (UNII: K0KQV10C35)
- POVIDONE K90 (UNII: RDH86HJV5Z)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SODIUM CARBONATE (UNII: 45P3261C7T)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- HYPROMELLOSE 2208 (100 MPA.S) (UNII: B1QE5P712K)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 314200 - pantoprazole sodium 40 MG Delayed Release Oral Tablet
- RxCUI: 314200 - pantoprazole 40 MG Delayed Release Oral Tablet
- RxCUI: 314200 - pantoprazole 40 MG (as pantoprazole sodium sesquihydrate 45.1 MG) Delayed Release Oral Tablet
* Please review the full disclaimer at the bottom of this page.